112758-91-5

Basic information

• Product Name: 1-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROPYRROLO[1,2-A]PYRAZINE
• Synonyms: IFLAB-BB F1386-0111;1-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROPYRROLO[1,2-A]PYRAZINE
• CAS NO: 112758-91-5
• Molecular Formula: C₁₃H₁₃ClN₂
• Molecular Weight: 232.71
• Mol File: 112758-91-5.mol

Chemical Properties

• Boiling Point: 144-146 °C(Press: 2 Torr)
• Appearance: /
• Density: 1.28±0.1 g/cm3(Predicted)
• PKA: 6.46±0.40(Predicted)
• CAS DataBase Reference: 1-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROPYRROLO[1,2-A]PYRAZINE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROPYRROLO[1,2-A]PYRAZINE(112758-91-5)
• EPA Substance Registry System: 1-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROPYRROLO[1,2-A]PYRAZINE(112758-91-5)

Safety Data

• Hazard Codes: T
• Statements: 25
• Safety Statements: 45
• Hazardous Substances Data: 112758-91-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
1-(4-Chlorophenyl)-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine is used as a building block for the synthesis of bioactive compounds due to its unique chemical structure and potential pharmaceutical properties. Its heterocyclic nature and the presence of a chlorine atom attached to the phenyl group make it a promising candidate for the development of new drugs and therapeutic agents.
Used in Medicinal Chemistry Research:
1-(4-Chlorophenyl)-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine is used as a subject of study in medicinal chemistry research to explore its potential applications and properties. 1-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROPYRROLO[1,2-A]PYRAZINE's structure and characteristics provide valuable insights into the design and synthesis of new bioactive molecules, which could lead to the development of innovative treatments for various diseases and conditions.

Upstream product

• 111609-57-5 1-(4-Chloro-phenyl)-3,4-dihydro-pyrrolo[1,2-a]pyrazine 

Relevant articles and documents

Substituted Tetrahydropyrrolopyrazine Compounds and the Use Thereof in the Treatment and/or Inhibition of Pain

Substituted tetrahydropyrrolopyrazine compounds corresponding to the formula I: processes for their preparation, pharmaceutical compositions comprising these compounds and the use of these compounds for the treatment and/or inhibition of pain and other disorders or disease states at least partly mediated by KCNQ2/3 K+ channels.